Prioritizing susceptibility genes for the prognosis of male-pattern baldness with transcriptome-wide association study

© 2024. The Author(s)..

BACKGROUND: Male-pattern baldness (MPB) is the most common cause of hair loss in men. It can be categorized into three types: type 2 (T2), type 3 (T3), and type 4 (T4), with type 1 (T1) being considered normal. Although various MPB-associated genetic variants have been suggested, a comprehensive study for linking these variants to gene expression regulation has not been performed to the best of our knowledge.

RESULTS: In this study, we prioritized MPB-related tissue panels using tissue-specific enrichment analysis and utilized single-tissue panels from genotype-tissue expression version 8, as well as cross-tissue panels from context-specific genetics. Through a transcriptome-wide association study and colocalization analysis, we identified 52, 75, and 144 MPB associations for T2, T3, and T4, respectively. To assess the causality of MPB genes, we performed a conditional and joint analysis, which revealed 10, 11, and 54 putative causality genes for T2, T3, and T4, respectively. Finally, we conducted drug repositioning and identified potential drug candidates that are connected to MPB-associated genes.

CONCLUSIONS: Overall, through an integrative analysis of gene expression and genotype data, we have identified robust MPB susceptibility genes that may help uncover the underlying molecular mechanisms and the novel drug candidates that may alleviate MPB.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:18

Enthalten in:

Human genomics - 18(2024), 1 vom: 02. Apr., Seite 34

Sprache:

Englisch

Beteiligte Personen:

Choi, Eunyoung [VerfasserIn]
Song, Jaeseung [VerfasserIn]
Lee, Yubin [VerfasserIn]
Jeong, Yeonbin [VerfasserIn]
Jang, Wonhee [VerfasserIn]

Links:

Volltext

Themen:

Drug repositioning
Gene prioritization
Journal Article
Male-pattern baldness
Phenome-wide association study
Transcriptome-wide association study

Anmerkungen:

Date Completed 04.04.2024

Date Revised 06.04.2024

published: Electronic

Citation Status MEDLINE

doi:

10.1186/s40246-024-00591-y

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM370556968